Illinois regulators reschedule review related to Advocate Aurora-Atrium deal


An Illinois regulatory panel that delayed an approval needed for Advocate Aurora Health to proceed with a proposed business combination with Atrium Health is scheduled to reconvene on the matter Nov. 14.

Previous Valeas Capital Partners makes $200M investment in Sequoia Financial Group
Next The Funded: California may not be No. 1 for IPOs this year for the first time since 2003